Epidemiology and molecular genetics of colorectal cancer in Iran: A review

Archives of Iranian Medicine

Volumn 12, Issue 2, 2009, Pages 161-169

  Malekzadeh, Reza ^a   Bishehsari, Faraz ^a,b   Mahdavinia, Mahboobeh ^a,b   Ansari, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Colorectal cancer; Epidemiology; Iran; Molecular genetics

Indexed keywords

APC PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53;

CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CPG ISLAND; FAMILY STUDY; GENE MUTATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; IRAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR GENETICS; REVIEW; AGE; COLORECTAL TUMOR; GENETICS; MASS SCREENING; MOLECULAR BIOLOGY;

AGE FACTORS; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MASS SCREENING; MOLECULAR BIOLOGY;

EID: 67649756980     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality, and Prevalence Worldwide, Version 2.0. IARC Cancer Base Number 5. Lyon: IARC Press; 2004.
2. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006; 30: 14-19.
3. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2008 Dec 10.
4. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107: 113-118.
5. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekzadeh R, Parkin DM. Cancer occurrence in Iran in 2002: an international perspective. Asian Pac J Cancer Prev. 2005; 6: 359-363.
6. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett. 2006; 240: 143-147.
7. Hosseini SV, Izadpanah A, Yarmohammadi H. Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980 - 2000. ANZ J Surg. 2004; 74: 547-549.
8. Yazdizadeh B, Jarrahi AM, Mortazavi H, Mohagheghi MA, Tahmasebi S, Nahvijo A. Time trends in the occurrence of major GI cancers in Iran. Asian Pac J Cancer Prev. 2005; 6: 130-134.
9. Sung JJ, Lau JY, Goh KL, Leung WK, Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6: 871-876.
10. Dunn JE. Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res. 1975; 35: 3240-3245.
11. McMichael AJ, Giles GG. Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res. 1988; 48: 751-756.
12. You W, Jin F, Gridley G, Schatzkin A, Yang G, Rosenberg P, et al. Trends in colorectal cancer rates in urban Shanghai, 1972 - 1996, in relation to dietary changes. Ann Epidemiol. 2000; 10: 449-483.
13. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst. 1999; 91: 916-932.
14. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR; 2007.
15. Djazayery A, Pajooyan J. Food consumption patterns and nutritional problems in the Islamic Republic of Iran. Nutr Health. 2000; 14: 53-61.
16. Azizi F, Allahverdian S, Mirmiran P, Rahmani M, Mohammadi F. Dietary factors and body mass index in a group of Iranian adolescents: Tehran lipid and glucose study - 2. Int J Vitam Nutr Res. 2001; 71: 123-127.
17. Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr. 2002; 5: 149-155.
18. Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M,et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006; 7: 86-90.
19. Kudo S, Tamure S, Nakajima T, Hirota S, Asano M, Ito O, et al. Depressed type of colorectal cancer. Endoscopy. 1995; 27: 54-57.
20. Hasegawa H, Ueda M, Watanabe M, Teramoto T, Mukai M, Kitajima M. K-ras gene mutations in early colorectal cancer: flat elevated vs. polyp-forming cancer. Oncogenes. 1995; 10: 1413-1416.
21. Uronis JM, Herfarth HH, Rubinas TC, Bissahoyo AC, Hanlon K, Threadgill DW. Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage. Cancer Res. 2007; 67: 11594-11600.
22. Chen CD, Yen MF, Wang WM, Wong JM, Chen THH. A case- control study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer. 2003; 88: 1866-1873.
23. Fazeli MS, Adel MG, Lebaschi AH. Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University. Dis Colon Rectum. 2007; 50: 990-995.
24. Azadeh S, Moghimi-Dehkordi B, Fatem SI, Pourhoseingholi M, Ghiasi S, Zali M. Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev. 2008; 9: 123-126.
25. Griffin PM, Liff JM, Greenberg RS, Clark WS. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology. 1991; 100: 1033-1040.
26. Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, Faivre J. Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum. 2001; 44: 380-387.
27. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003; 348: 919-932.
28. Vasen HF. The Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther. 2007; 26 (suppl 2): 113-126.
29. Grady WM. Molecular basis for subdividing hereditary colon cancer. Gut. 2005; 54: 1676-1678.
30. Mahdavinia M, Bishehsari F, Ansari R, Norouzbeigi N, Khaleghinejad A, Hormazdi M, et al. Family history of colorectal cancer in Iran. BMC Cancer. 2005; 5: 112.
31. Hatch SB, Lightfoot HM Jr, Garwacki CP, Moore DT, Calvo BF, Woosley JT, et al. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors. Clin Cancer Res. 2005; 11: 2180-2187.
32. Bishehsari F, Mahdavinia M, Malekzadeh R, Verginelli F, Catalano T, Sotoudeh M, et al. Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. Ann Oncol. 2006; 17: vii91-vii96.
33. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759-767.
34. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007; 318: 1108-1113.
35. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, et al. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res. 2005; 11: 8281-8287.
36. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M, et al. Associations between dietary intake and K-ras mutations in colon tumors: a population-based study. Cancer Res. 2000; 60: 6935-6941.
37. Chatenoud L, La Vecchia C, Franceschi S, Tavani A, Jacobs DR Jr, Parpinel MT, et al. Refined-cereal intake and risk of selected cancers in Italy. Am J Clin Nutr. 1999; 70: 1107-1110.
38. Mahdavinia M, Bishehsari F, Verginelli F, Cumashi A, Lattanzio R, Sotoudeh M, et al. p53 mutations in colorectal cancer from northern Iran: relationships with site of tumor origin, microsatellite instability, and K-ras mutations. J Cell Physiol. 2008; 216: 543-550.
39. McDermott U, Longley DB, Johnston PG. Molecular and biochemical markers in colorectal cancer. Ann Oncol. 2002; 13: 235-245.
40. Frigola J, Solé X, Paz MF, Moreno V, Esteller M, Capellà G, et al. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet. 2005; 14: 319-326.
41. Biramijamal F, Allameh A, Mirbod P, Groene HJ, Koomagi R, Hollstein M. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res. 2001; 61: 3119-3123.
42. Sepehr A, Tanière P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, et al. Distinct pattern of Tp53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene. 2001; 20: 7368-7374.
43. Mokarram P, Naghibalhossaini F, Saberi- Firoozi M, Hosseini SV, Izadpanah A, Salahi H, et al. Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J Gastroenterol. 2008; 14: 3662-3671.
44. Motlagh A, Azadeh P, Fazlalizadeh A, Shahrad B, Shafaghi B, Fudazi M, et al. Expression of epidermal growth factor receptor as a predictive factor for rectal cancer. Arch Iran Med. 2007; 10: 301-308.
45. Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis. 2008 May 3.
46. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis. 2008; 23: 683-688.
47. Haghighi P, Nasr K, Mohallate EA, Ghassemi H, Sadri S, Nabizadeh I, et al. Colorectal polyps and carcinoma in southern Iran. Cancer. 1977; 39: 274-278.
48. O'Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004; 187: 343-348.